Pages that link to "Q34723434"
Jump to navigation
Jump to search
The following pages link to Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease (Q34723434):
Displaying 50 items.
- Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex (Q24599546) (← links)
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy (Q24628821) (← links)
- Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation (Q28364488) (← links)
- Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice (Q28551832) (← links)
- A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies (Q30496656) (← links)
- Induction of human gamma globin gene expression by histone deacetylase inhibitors (Q33598588) (← links)
- Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F induction (Q33598612) (← links)
- Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury (Q33613257) (← links)
- Butyrate increases the efficiency of translation of gamma-globin mRNA. (Q33677601) (← links)
- CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood (Q33713346) (← links)
- Generation of a genomic reporter assay system for analysis of γ- and β-globin gene regulation (Q33729627) (← links)
- The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice (Q33754648) (← links)
- Quantitative analysis of globin gene induction in single human erythroleukemic cells (Q33857209) (← links)
- Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo (Q33922774) (← links)
- Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway (Q34106928) (← links)
- Design of embedded chimeric peptide nucleic acids that efficiently enter and accurately reactivate gene expression in vivo (Q34165634) (← links)
- Identification and characterization of mechanistically distinct inducers of gamma-globin transcription (Q34313801) (← links)
- Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives (Q34662684) (← links)
- Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress (Q34668049) (← links)
- Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models (Q34678844) (← links)
- Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo (Q34723868) (← links)
- Fetal hemoglobin in sickle cell anemia (Q35114500) (← links)
- Pharmacotherapy in sickle cell disease--state of the art and future prospects (Q35220342) (← links)
- Sickle cell disease: old discoveries, new concepts, and future promise (Q35723452) (← links)
- Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex (Q35849050) (← links)
- The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus (Q35867539) (← links)
- Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study (Q35882386) (← links)
- FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors (Q35986327) (← links)
- EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. (Q36169265) (← links)
- Regulation of human fetal hemoglobin: new players, new complexities (Q36234547) (← links)
- Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin (Q36384893) (← links)
- Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma (Q36478403) (← links)
- Epigenetic analysis of the human alpha- and beta-globin gene clusters (Q36502363) (← links)
- Butyrate histone deacetylase inhibitors. (Q36574546) (← links)
- Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease (Q36596855) (← links)
- Hydroxyurea for children with sickle cell disease (Q36612962) (← links)
- Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway (Q36963138) (← links)
- Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia (Q36968042) (← links)
- Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation (Q37008748) (← links)
- Current management of sickle cell anemia (Q37040238) (← links)
- Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease (Q37071189) (← links)
- Prodrugs for the treatment of neglected diseases. (Q37157236) (← links)
- Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin (Q37162080) (← links)
- Epigenetics of beta-globin gene regulation (Q37257146) (← links)
- Short-chain fatty acid-mediated effects on erythropoiesis in primary definitive erythroid cells (Q37262442) (← links)
- Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. (Q37524864) (← links)
- A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease (Q37524888) (← links)
- Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease (Q37677221) (← links)
- Pharmacologic Induction of Fetal Hemoglobin Production (Q37809339) (← links)
- Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries (Q37832963) (← links)